FIGURE 1.

Three levels of drug disposition: The nanomedicine faces three levels of dispositions before reaching its final target. First, they enter the tumor tissue, where multiple complex factors in the tumor microenvironment limit their delivery; second, they follow cellular endocytosis mechanisms and enter inside the tumor cell and exert desired therapeutic effects. Finally, the drug candidate inside nanomedicine reaches individual organelles to exhibit its action mechanism.